Back to Treatments

Treatment

NECT (Nifurtimox-Eflornithine Combination Therapy)

1
Conditions
2
Trials
2,000
Participants
55%
Average Safety

Condition Evidence

African trypanosomiasis

2 trials · 2,000 participants

96% effectiveness · 55% safety
NECT (Nifurtimox-Eflornithine Combination Therapy) | DFDA